Instrument Inactif

Autres langues GW Pharmaceuticals plc London S.E.

Actions

GB0030544687

Cours en clôture London S.E. Autres places de cotation
- ^GBX	-

2021	La filiale de Jazz Pharmaceuticals obtient l'approbation du Royaume-Uni pour Epidyolex chez les patients souffrant de crises liées au complexe de sclérose tubéreuse.	MT
2021	Jazz Pharmaceuticals met à jour ses prévisions pour l'année 2021 après le rachat de GW Pharmaceuticals	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Fitch Affirms Jazz's IDR at 'BB-'; Outlook Positive	06/04/23
Former President of GW Pharmaceuticals USA Joins Lexaria Bioscience as Strategic Advisor	23/01/23
Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing	28/03/22
JAZZ PHARMACEUTICALS ANNOUNCES FULL YEAR AND FOURTH QUARTER 2021 FINANCIAL RESULTS	02/03/22
Jazz Pharmaceuticals : U.S. FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav	12/08/21
Sector Update: Health Care Stocks Steady Premarket Tuesday	10/08/21
Jazz Pharmaceuticals : GW Pharmaceuticals Bags UK Nod for New Use of Cannabis-Based Seizure Drug	10/08/21
Jazz Pharmaceuticals' : Subsidiary Gets UK Approval for Epidyolex in Patients With Tuberous Sclerosis Complex-Related Seizures	10/08/21
Gw Pharmaceuticals Receives Approval for Epidyolex (Cannabidiol) from the MHRA for the Treatment of Seizures Associated with Tuberous Sclerosis Complex	10/08/21
HINTERGRUND/Bei Pharma-Übernahmen schlagen inzwischen oft Midcaps zu	06/07/21
Jazz Pharmaceuticals : Updates 2021 Full-Year Guidance Following GW Pharmaceuticals Buy	17/06/21
Jazz Pharmaceuticals : Updates FY2021 Outlook to Reflect GW Pharmaceuticals Purchase	17/06/21
Palla Pharma : Names New CEO; Shares Soar 18%	26/05/21
Alkame : PAO Group, Inc.'s CBD Nutraceuticals Expected To Deliver Revenue-Generating Catalyst in 2021; New Partnerships Expand Its Long-Term CBD Pharmaceutical Programs	12/05/21
GW Pharmaceuticals plc(NasdaqGM:GWPH) dropped from S&P Global BMI Index	10/05/21
PAO Group, With A CRO On Its Side, Could Deliver Its First CBD-Based Therapeutic By Year's End	06/05/21
GW PHARMACEUTICALS PLC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	05/05/21
Jazz Pharmaceuticals : Completes Purchase of GW Pharmaceuticals	05/05/21
GW Pharmaceuticals : Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc	05/05/21
GW Pharmaceuticals plc(NasdaqGM:GWPH) dropped from NASDAQ Composite Index	05/05/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues GW Pharmaceuticals plc London S.E.

Actions

GB0030544687

Autres langues

Filtres